Logotipo do repositório
 

Publicação:
Inflammatory markers in saliva for diagnosis of sepsis of hospitalizes patients

dc.contributor.authorGalhardo, Luciana Freitas
dc.contributor.authorRuivo, Gilson Fernandes
dc.contributor.authorde Oliveira, Luciane Dias [UNESP]
dc.contributor.authorParize, Graziele
dc.contributor.authorSantos, Silvana Soléo Ferreira Dos
dc.contributor.authorPallos, Debora
dc.contributor.authorLeão, Mariella Vieira Pereira
dc.contributor.institutionUNITAU - University of Taubaté
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.contributor.institutionUNISA - University of Santo Amaro
dc.contributor.institutionHUMANITAS - School of Medical Sciences of São José dos Campos
dc.date.accessioned2020-12-12T01:18:48Z
dc.date.available2020-12-12T01:18:48Z
dc.date.issued2020-05-01
dc.description.abstractBackground: Inflammatory/immunological serum markers are useful for the early detection of organ dysfunction, helping the diagnosis of sepsis. Although the detection of blood biomarkers is a standard practice, the use of noninvasive samples (eg saliva) would be beneficial. Aim: To investigate the saliva of hospitalized patients with and without sepsis and identify the levels of inflammatory markers such as C-reactive protein (CRP), procalcitonin (PCT), interleukin 6 (IL-6) and nitric oxide (NO). Methods: Saliva samples were collected from 26 patients in intensive care unit with diagnosis of sepsis and from 26 without sepsis (control). The levels of CRP were determined by using latex agglutination test, whereas those of procalcitonin and IL-6 by ELISA and NO by the Griess reaction. Results: Of 26 patients with sepsis, 14 were males (54%) with a mean age of 63.81 ± 3.48 years. The control group had the same distribution for gender, with mean age 65.04 ± 4.07 years. Sepsis group showed higher salivary concentrations of CRP, PCT, IL-6 and NO, with only levels of IL-6 being statistically different (P =.0001). Conclusions: Patients with sepsis had significantly higher levels of IL-6 in their saliva, suggesting that this biological sample could be useful in the diagnosis of this condition.en
dc.description.affiliationUNITAU - University of Taubaté
dc.description.affiliationUNESP – State of São Paulo University
dc.description.affiliationUNISA - University of Santo Amaro
dc.description.affiliationHUMANITAS - School of Medical Sciences of São José dos Campos
dc.description.affiliationUnespUNESP – State of São Paulo University
dc.identifierhttp://dx.doi.org/10.1111/eci.13219
dc.identifier.citationEuropean Journal of Clinical Investigation, v. 50, n. 5, 2020.
dc.identifier.doi10.1111/eci.13219
dc.identifier.issn1365-2362
dc.identifier.issn0014-2972
dc.identifier.scopus2-s2.0-85082187740
dc.identifier.urihttp://hdl.handle.net/11449/198662
dc.language.isoeng
dc.relation.ispartofEuropean Journal of Clinical Investigation
dc.sourceScopus
dc.subjectbiomarkers
dc.subjectintensive care unit
dc.subjectsaliva
dc.subjectsepsis
dc.titleInflammatory markers in saliva for diagnosis of sepsis of hospitalizes patientsen
dc.typeArtigo
dspace.entity.typePublication
unesp.author.orcid0000-0003-2304-8667[1]
unesp.author.orcid0000-0002-9388-8111[2]
unesp.author.orcid0000-0001-9956-7768[3]
unesp.author.orcid0000-0002-3463-7865[4]
unesp.author.orcid0000-0001-5827-7721[5]
unesp.author.orcid0000-0001-7426-1041[6]
unesp.author.orcid0000-0003-1949-3207[7]

Arquivos

Coleções